Navigation Links
Men and women receive different fertility advice following cancer diagnosis
Date:5/29/2012

There are significant gaps in the information women receive about their future fertility following cancer diagnosis, suggests a new paper published today (30 May) in BJOG: An International Journal of Obstetrics and Gynaecology.

Infertility can be a side-effect of cancer treatment and there are increasing numbers of people of reproductive age undergoing such treatment.

This study - led by the University of Aberdeen and NHS Grampian - looks at perceptions and use of fertility preservation techniques in both men and women of reproductive age who have recently been diagnosed with cancer.

It is the first study to explore the experience of discussing future fertility at the time of cancer diagnosis amongst younger men and women.

Sixteen men and 18 women aged 17-49 took part along with 15 health professionals concerned in cancer care. Patients were receiving treatment for blood related and other cancers between August 2008 and June 2010.

Patients were interviewed soon after their first consultation after a diagnosis of cancer had been made. Topics discussed included: patients' perceptions and understanding of the initial diagnosis, the prognosis and their future reproductive choices; perceived quality and source of information received, communication and support; and the role of partners, family members, friends and healthcare professionals.

In addition, staff were asked about their opinions on the information given to younger people with cancer, their knowledge and views of the treatments available with respect to fertility preservation and their perceptions of patients' priorities.

The paper found that almost all of the patients had been given written information about cancer treatment, which included a small section on fertility preservation.

Men and women were given different information reflecting the varying fertility preservation options available, perceived success rates and subsequent delay in accessing cancer treatment.

Men were actively encouraged to consider storage of sperm, even if they had children already. Nearly all had a discussion with staff about sperm banking and a local protocol was in place for immediate referral.

However, in contrast, few women interviewed could remember fertility preservation being discussed and there was no protocol in place.

From the staff interviews, the main reason why staff did not discuss fertility preservation with the majority of women was their belief that treatment was perceived to be more urgent. The study also found that health professionals did not discuss future fertility in detail because they felt patients were given a wealth of information during their first visit and that fertility would not be affected if treatment using first line drugs was successful.

Valerie Peddie, Fertility Nurse Specialist/Research Midwife, School of Medicine and Dentistry, University of Aberdeen, and co-author of the paper said:

"It has been widely argued that at the time of diagnosis, patients should be provided with accurate information about the potential risk of impaired fertility after treatment for cancer irrespective of whether local facilities for gamete cryopreservation exist.

"However in reality, the immediate emphasis is often on treatment, with little time available to discuss future fertility or options for fertility preservation.

"Our study has demonstrated significant gaps in the information provided to young women diagnosed with cancer and suggests the need for an early appointment with a fertility expert."

BJOG Deputy Editor-in-Chief, Pierre Martin-Hirsch, added:

"This is a unique study as it looks specifically at younger men and women's experiences however it is a small scale study and more research needs to be conducted in a larger population. Following that care pathways should be developed looking at fertility and cancer treatment."


'/>"/>

Contact: Naomi Weston
nweston@rcog.org.uk
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Gum disease joins hot flashes and PMS associated with womens hormones
2. Night Shift Might Boost Womens Breast Cancer Risk: Study
3. Fitness May Boost Survival for Women With Breast Cancer
4. Fewer Stillbirths Among Pregnant Women Vaccinated Against Flu
5. 70 percent of women use contraceptives during their first sexual encounter
6. Phone contact with nurses linked with better outcomes for women with gestational diabetes
7. Vitamin C improves lung function in newborns of pregnant smoking women
8. Vitamin C improves pulmonary function in newborns of pregnant smoking women
9. Women fare better than men, but need more blood after kidney cancer surgery
10. For highly educated women, families are an increasingly popular option
11. UTSA study finds ovulating women perceive sexy cads as good dads
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
(Date:12/8/2016)... ... 2016 , ... STAT courier is pleased to announce that due to customer ... are expanding their presence in Dallas. One of the most exciting parts for STAT ... to the Dallas and Forth Worth market. STAT takes pride in treating their employees ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Vida ... an $18M Series B led by Canvas Ventures . Other investors include Nokia ... scale its mobile platform to serve more consumers who are managing chronic conditions ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
(Date:12/8/2016)... Research and Markets has announced the addition of the ... ... global chromatography market to grow at a CAGR of 5.42% during the ... based on an in-depth market analysis with inputs from industry experts. The ... years. The report also includes a discussion of the key vendors operating ...
(Date:12/8/2016)... 8, 2016  Economic growth in the United States ... supply management executives in their December 2016 Semiannual Economic ... recovery that began in mid-2009, as indicated in the ... ® . The manufacturing sector is optimistic about growth ... manufacturing industries, and the non-manufacturing sector indicates that 14 ...
Breaking Medicine Technology: